GENEVA, May 12 -- HANMI PHARM. CO., LTD. (214, Muha-ro, Paltan-myeon,Hwaseong-si,Gyeonggi-do 18536), 한미약품 주식회사 (경기도화성시팔탄면 무하로 214) filed a patent application (PCT/KR2025/017716) for "COMBINATION THERAPY OF INTERLEUKIN-2 ANALOG OR CONJUGATE THEREOF AND CTLA -4 ANTAGONIST FOR PREVENTION OR TREATMENT OF CANCER" on Oct 31, 2025. With publication no. WO/2026/095711, the details related to the patent application was published on May 07, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organizati...